Thalassemia.
D002614:Chelating Agents / Q000627:therapeutic use*; D003365:Costs and Cost Analysis; D003676:Deferoxamine / Q000008:administration & dosage / Q000627:therapeutic use*; D006801:Humans; D007501:Iron / Q000378:metabolism / Q000633:toxicity; D013789:Thalassemia / Q000188:drug therapy* / Q000628:therapy; D065227:Transfusion Reaction
D002614:Chelating Agents; D007501:Iron; D003676:Deferoxamine